Müller-Vahl K - Search Results

1

Tourette syndrome research highlights from 2023.

Hartmann A, Andrén P, Atkinson-Clement C, Czernecki V, Delorme C, Mol Debes N, Morand-Beaulieu S, Müller-Vahl K, Paschou P, Szejko N, Topaloudi A, Black KJ. Hartmann A, et al. Among authors: muller vahl k. F1000Res. 2024 Aug 9;13:677. doi: 10.12688/f1000research.150931.2. eCollection 2024. F1000Res. 2024. PMID: 39296887 Free PMC article. Review.

2

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome.

Müller-Vahl KR, Kolbe H, Schneider U, Emrich HM. Müller-Vahl KR, et al. Acta Psychiatr Scand. 1998 Dec;98(6):502-6. doi: 10.1111/j.1600-0447.1998.tb10127.x. Acta Psychiatr Scand. 1998. PMID: 9879795

3

Dopamine D2 receptor imaging in Gilles de la Tourette syndrome.

Müller-Vahl KR, Berding G, Kolbe H, Meyer GJ, Hundeshagen H, Dengler R, Knapp WH, Emrich HM. Müller-Vahl KR, et al. Acta Neurol Scand. 2000 Mar;101(3):165-71. doi: 10.1034/j.1600-0404.2000.101003165.x. Acta Neurol Scand. 2000. PMID: 10705938

4

Cannabinoids reduce symptoms of Tourette's syndrome.

Müller-Vahl KR. Müller-Vahl KR. Expert Opin Pharmacother. 2003 Oct;4(10):1717-25. doi: 10.1517/14656566.4.10.1717. Expert Opin Pharmacother. 2003. PMID: 14521482 Review.

5

Altered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndrome.

Heise KF, Steven B, Liuzzi G, Thomalla G, Jonas M, Müller-Vahl K, Sauseng P, Münchau A, Gerloff C, Hummel FC. Heise KF, et al. Brain. 2010 Feb;133(Pt 2):580-90. doi: 10.1093/brain/awp299. Epub 2009 Dec 11. Brain. 2010. PMID: 20008030

6

Health-related quality of life in patients with Gilles de la Tourette's syndrome.

Müller-Vahl K, Dodel I, Müller N, Münchau A, Reese JP, Balzer-Geldsetzer M, Dodel R, Oertel WH. Müller-Vahl K, et al. Mov Disord. 2010 Feb 15;25(3):309-14. doi: 10.1002/mds.22900. Mov Disord. 2010. PMID: 20063404

7

Tourette's syndrome.

Müller-Vahl KR. Müller-Vahl KR. Curr Top Behav Neurosci. 2009;1:397-410. doi: 10.1007/978-3-540-88955-7_17. Curr Top Behav Neurosci. 2009. PMID: 21104394

8

European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment.

Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, Czernecki V, Robertson MM, Martino D, Munchau A, Rizzo R; ESSTS Guidelines Group. Cath DC, et al. Eur Child Adolesc Psychiatry. 2011 Apr;20(4):155-71. doi: 10.1007/s00787-011-0164-6. Eur Child Adolesc Psychiatry. 2011. PMID: 21445723 Free PMC article.

9

European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ; ESSTS Guidelines Group. Roessner V, et al. Eur Child Adolesc Psychiatry. 2011 Apr;20(4):173-96. doi: 10.1007/s00787-011-0163-7. Eur Child Adolesc Psychiatry. 2011. PMID: 21445724 Free PMC article.

10

European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions.

Verdellen C, van de Griendt J, Hartmann A, Murphy T; ESSTS Guidelines Group. Verdellen C, et al. Eur Child Adolesc Psychiatry. 2011 Apr;20(4):197-207. doi: 10.1007/s00787-011-0167-3. Eur Child Adolesc Psychiatry. 2011. PMID: 21445725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters